FCMV
THRX
Foresite Capital Management V’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,108,796
| Closed | -$16.6M | – | 6 |
|
|
2023
Q4 | $16.6M | Hold |
4,108,796
| – | – | 22.67% | 2 |
|
|
2023
Q3 | $11.1M | Buy |
4,108,796
+523,450
| +15% | +$1.41M | 17.63% | 3 |
|
|
2023
Q2 | $33.5M | Hold |
3,585,346
| – | – | 24.43% | 2 |
|
|
2023
Q1 | $31.8M | Hold |
3,585,346
| – | – | 23.54% | 2 |
|
|
2022
Q4 | $17.9M | Buy |
3,585,346
+250,000
| +7% | +$1.25M | 13.87% | 4 |
|
|
2022
Q3 | $19.3M | Hold |
3,335,346
| – | – | 14.87% | 2 |
|
|
2022
Q2 | $18.4M | Buy |
3,335,346
+122,614
| +4% | +$678K | 12.89% | 2 |
|
|
2022
Q1 | $37M | Hold |
3,212,732
| – | – | 15.13% | 2 |
|
|
2021
Q4 | $40.7M | Buy |
+3,212,732
| New | +$40.7M | 10.01% | 3 |
|